ストックスクリーナーアプリを入手
93.47
0.19%
-0.18
プレマーケット:
93.83
0.36
+0.39%
前日終値:
$93.65
開ける：
$93.59
24時間の取引高:
7.79M
Relative Volume:
0.81
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.52%
1か月 パフォーマンス:
+7.66%
6か月 パフォーマンス:
+8.52%
1年 パフォーマンス:
-5.13%
1日の値動き範囲:
$92.49
$93.97
1週間の範囲:
$89.33
$94.86
52週間の値動き範囲:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
XBI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
93.47 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
320.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
649.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
652.21 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
575.23 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf (XBI) 最新ニュース
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
(XBI) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
Liquidity Mapping Around (XBI) Price Events - news.stocktradersdaily.com
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
How (XBI) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
XBI ETF Implied Analyst Target Price: $139.15 per unit, with 54.74% upside from current price of $89.92 per unit. - AInvest
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Noteworthy ETF Inflows: XBI, ALNY, HALO, INSM - Nasdaq
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
(XBI) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
Exploring the SPDR S&P Biotech ETF (XBI) for Biotech Industry Exposure - AInvest
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Assessing the Political and Policy Risks in the 2028 U.S. Presidential Race and Their Impact on Health and Biotech Sectors - AInvest
Health and Human Services Secretary Robert F. Kennedy Jr. Disavows 2028 Presidential Run, Pledges Loyalty to Trump. - AInvest
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
7 Best Biotech ETFs to Buy Now - US News Money
ETF Talk: Create the Future with This ETF - Stock Investor
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF - Nasdaq
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 of the Best AI ETFs to Buy for 2025 - US News Money
Prasad’s FDA Return Adds to Leadership Turmoil at U.S. Health Agencies - Barron's
FDA Leadership Shifts and Their Impact on Biotech Valuations: Navigating Regulatory Risk in the Post-Vinay Prasad Era - AInvest
Regulatory Leadership Volatility: How FDA Reinstatements Reshape Biotech Investment Landscapes - AInvest
The AI-Driven Medtech Revolution: Why Heartflow's IPO Signals a Strategic Buy in a Shifting Market - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
QQQ Tops Daily ETF Inflows - ETF.com
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
The World’s First AI Genome Editor - Brownstone Research
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
(08/04/25) BBH: A Biotech Fund That’s Ripe for a Major Turnaround - moneyshow.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Growth in Short Interest - Defense World
Spdr Biotech Etf (XBI) 財務データ
Spdr Biotech Etf (XBI) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.74%
大文字化:
|
ボリューム (24 時間):